Skip to main content

Table 1 Demographic and clinical characteristics of study patients according to ORNJ

From: Progression and postoperative complications of osteoradionecrosis of the jaw: a 20-year retrospective study of 124 non-nasopharyngeal cancer cases and meta-analysis

Variable

 

No. of patients

124

Mean (SD) range (years)

57.6 (10.1), 32–83

Sex (male/female)

89/35

Chemoradiotherapy/ Radiotherapy only

46/78

Type of primary tumor:

 Tongue carcinoma

41 (33.1%)

 Gingival carcinoma

10 (8.1%)

 Buccal carcinoma

9 (7.3%)

 Mouth floor carcinoma

11 (8.9%)

 Oropharyngeal carcinoma

23 (18.5%)

 Hard palate carcinoma

3 (2.4%)

 Salivary gland carcinoma

6 (4.8%)

 Carcinoma of jaw

3 (2.4%)

 Maxillary sinus carcinoma

4 (3.2%)

 Other

14 (11.3%)

Mean (SD) range time from end of radiotherapy to development of osteonecrosis of the jaws

4.5 (5.1) years, 1 months-32 years

  1. ORNJ osteoradionecrosis of jaw; SD standard deviation; No. number